Treatment-related symptoms during the first year following transperineal 125I prostate implantation
International Journal of Radiation Oncology*Biology*PhysicsPublished 1 March 1994
Lawrence Kleinberg, Kent E. Wallner, Jitendra Nath Roy, Michael J. Zeléfsky, V. Elayne Arterbery, Zvi Fuks
Citations126
SJR quartileQ1
SJR score2.06
SNIP1.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
125I implantation, as performed in this series, is generally associated with only mild-moderate genitourinary and rectal symptoms that may persist 6 months or more after implantation.
Abstract
125I implantation, as performed in this series, is generally associated with only mild-moderate genitourinary and rectal symptoms that may persist 6 months or more after implantation. Prostatic carcinoma, Brachytherapy, Morbidity.
Keywords
Medicine
Springer series in statisticsNonparametric Estimation from Incomplete Observations
45,533 Citations1992Edward L. Kaplan, Paul Meier
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
39,052 Citations1958Edward L. Kaplan, Paul Meier
International Journal of Radiation Oncology*Biology*PhysicsLong-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
428 Citations1991C.A. Lawton, Minhee Won +9 more
These data from two large multi-institutional trials represent a fair estimate of the actual incidence of major intestinal and urinary complications from external beam irradiation in the management of local and locoregional adenocarcinoma of the prostate.
PubMedTransperineal ultrasound-guided implantation of the prostate: morbidity and complications.
194 Citations1991John C. Blasko, Haakon Ragde +1 more
Transperineal implantation in the experience is associated with an acceptable acute and chronic complication rate and in patients with early carcinoma of the prostate, most complications were mild to moderate with a notable absence of severe problems.
International Journal of Radiation Oncology*Biology*PhysicsThree-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study
173 Citations1994Steven A. Leibel, Ruth Heimann +12 more
Acute toxicity for the doses tested with this 3-dimensional conformal radiation therapy technique is reduced compared to traditional treatment techniques, and the initial tumor response as assessed by prostate specific antigen measurement is highly encouraging with prostatespecific antigen levels returning to normal in the majority of patients.
The Journal of UrologyComplications of <sup>125</sup> Iodine Implantation and Pelvic Lymphadenectomy in the Treatment of Prostatic Cancer
111 Citations1979Jackson E. Fowler, Winston Barzell +2 more
The operative, postoperative and late complications experienced by 300 consecutive patients who underwent 125iodine implantation and pelvic lymphadenectomy for localized prostatic cancer were analyzed.
The Journal of UrologyAn Improved Method For Computerized Tomography-Planned Transperineal <sup>125</sup> Iodine Prostate Implants
84 Citations1991Kent E. Wallner, Sou‐Tung Chiu‐Tsao +7 more
A computerized tomography-based treatment planning procedure that allows for angulation of transperineal needles to avoid the pubic bones and still reaches the most peripheral aspects of the gland is described.
International Journal of Radiation Oncology*Biology*PhysicsCT-based optimized planning for transperineal prostate implant with customized template
58 Citations1991Jitendra Nath Roy, Kent E. Wallner +3 more
A computerized planning procedure has been developed for CT-guided transperineal prostate implants that allows placement of I-125 seeds in the entire prostate gland while avoiding the pubic bones.
International Journal of Radiation Oncology*Biology*PhysicsShort-term morbidity from ct-planned transperineal I-125 prostate implants
56 Citations1993V. Elayne Arterbery, Kent Wallner +2 more
CT-guided transperineal prostate implants entail moderate, temporary urinary and rectral morbidity, and short-term tumor responses are encouraging.
UrologyGuided brachytherapy for treatment of confined prostate cancer
45 Citations1992Joseph B. Priestly, David Beyer
The preliminary results indicate that brachytherapy is a viable option to radical surgery in those patients who are not good candidates for surgery or who prefer nonsurgical treatment.
PubMedRole of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia.
43 Citations1990Herbert Lepor
There is sufficient evidence to justify the use of alpha blockers for men with moderate symptoms of prostatism, yet urologists may validly interpret the clinical experience with alpha blockers as preliminary, yet Urologists should at least present this option to patients before performing a prostatectomy.
PubMedIodine 125 brachytherapy for early stage prostate cancer: new techniques may achieve better results.
42 Citations1991Kent E. Wallner
Newer transperineal techniques, guided by transrectal ultrasound or CT scanning, have provided increased accuracy of seed placement, and early results with the newer techniques are promising.
UrologyUltrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma
32 Citations1989Peter Iversen, L. Nielsen +7 more
Thirty-three patients with localized prostatic carcinoma treated with transperineal 125Iodine seed implantation guided by transrectal ultrasonography and subsequent external beam irradiation were treated, revealing still malignant histology in 12 patients, and 8 have died of prostatic cancer.
International Journal of Radiation Oncology*Biology*PhysicsThree-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose escalation study
19 Citations1994Theodore L. Phillips
The previous generally held feeling that Stage B and limited Stage C prostate cancer was well controlled by radiotherapy with conventional doses of 65 to 70 Gy range has fallen, but it is clear that this local failure rate is much higher than previously thought.
The Journal of UrologyProstatorectal Fistula Associated with <sup>125</sup> Iodine Seed Radiotherapy
9 Citations1983K. Mouli, R. Sharifi +3 more
There are reports of 4 cases of prostatorectal fistula following 125iodine interstitial radiotherapy in men with localized prostate cancer.
American Journal of Clinical OncologyTransperineal 125Iodine Endocurietherapy of Prostate Cancer
7 Citations1988P. Pradeep Kumar, Roger R. Good +3 more
The improved implant technique, intraoperative and postoperative complications, local control, and survival of 67 patients with cancer of the prostate treated by means of percutaneous transperineal template permanent 125iodine interstitial endocurietherapy (ECT) are presented.
The Journal of UrologyDeoxyribonucleic Acid Cytometry and Histological Findings Before and After <sup>125</sup> Iodine Implantation of Primary Prostate Cancer
5 Citations1992Haakon Wæhre, Øystein Åmellem +5 more
The high frequency of nondiploid DNA stemlines 1 or more years after 125I implantation and the high rate of residual tumor leave some doubt about the radiocurability of prostate cancer by the chosen radiotherapy technique.